China Clinical Laboratory Test Market

ID: MRFR/HS/54669-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026
China Clinical Laboratory Test Market Research Report: By Type of Laboratory (Hospital-based, Central/Independent, Physician Office Laboratory, Others) andBy Type of Test (CBC and Routine Blood Test, Anatomic Pathology, Molecular Test, Immunology Test, Drug Test, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Clinical Laboratory Test Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)9.05%
2024 Market Size$ 9.25 Billion
2025 Market Size$ 10.09 Billion
2035 Market Size$ 24 Billion

Key Players

Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Danaher Corporation
Becton Dickinson and Company
Opportunities
  • Aging Population
  • Increasing Healthcare Expenditure
  • Government Initiatives and Policies
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Industrial Automation & Equipment, BY Type of Laboratories (USD Billion)
      1. 4.1.1 Rigid
      2. 4.1.2 Flexible
    2. 4.2 Industrial Automation & Equipment, BY Type of Tests (USD Billion)
      1. 4.2.1 Complete Blood Count (CBC)
      2. 4.2.2 Basic Metabolic Panel (BMP)
      3. 4.2.3 HbA1c Tests
      4. 4.2.4 HGB/HCT Tests
      5. 4.2.5 Comprehensive Metabolic Panel Tests
      6. 4.2.6 BUN Creatinine Tests
      7. 4.2.7 Renal Panel Tests
      8. 4.2.8 Electrolytes Testing
      9. 4.2.9 Liver Panel Tests & Lipid Panel Tests
    3. 4.3 Industrial Automation & Equipment, BY Application (USD Billion)
      1. 4.3.1 Parasitology
      2. 4.3.2 Virology
      3. 4.3.3 Hematology
      4. 4.3.4 Toxicology
      5. 4.3.5 Immunology/Serology
      6. 4.3.6 Histopathology and Urinalysis
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Diagnostics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Danaher Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Becton Dickinson and Company (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 bioMérieux SA (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Ortho Clinical Diagnostics (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY TYPE OF LABORATORIES
    3. 6.3 CHINA MARKET ANALYSIS BY TYPE OF TESTS
    4. 6.4 CHINA MARKET ANALYSIS BY APPLICATION
    5. 6.5 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
    8. 6.8 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    10. 6.10 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
    11. 6.11 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF LABORATORIES, 2024 (% SHARE)
    12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF LABORATORIES, 2024 TO 2035 (USD Billion)
    13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF TESTS, 2024 (% SHARE)
    14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE OF TESTS, 2024 TO 2035 (USD Billion)
    15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
    16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Billion)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE OF LABORATORIES, 2025-2035 (USD Billion)
      2. 7.2.2 BY TYPE OF TESTS, 2025-2035 (USD Billion)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type of Laboratories (USD Billion, 2025-2035)

  • Rigid
  • Flexible

Industrial Automation & Equipment By Type of Tests (USD Billion, 2025-2035)

  • Complete Blood Count (CBC)
  • Basic Metabolic Panel (BMP)
  • HbA1c Tests
  • HGB/HCT Tests
  • Comprehensive Metabolic Panel Tests
  • BUN Creatinine Tests
  • Renal Panel Tests
  • Electrolytes Testing
  • Liver Panel Tests & Lipid Panel Tests

Industrial Automation & Equipment By Application (USD Billion, 2025-2035)

  • Parasitology
  • Virology
  • Hematology
  • Toxicology
  • Immunology/Serology
  • Histopathology and Urinalysis